Intelligent Bio Solutions Inc (INBS)
1.64
+0.24
(+17.14%)
USD |
NASDAQ |
Nov 21, 16:00
1.69
+0.05
(+3.05%)
Pre-Market: 08:09
Intelligent Bio Solutions Debt to Equity Ratio: 0.0818 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0818 |
| June 30, 2024 | 0.0619 |
| March 31, 2024 | 0.0466 |
| December 31, 2023 | 0.1834 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.478 |
| June 30, 2023 | 0.199 |
| March 31, 2023 | 0.1984 |
| December 31, 2022 | 0.1311 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0466
Minimum
Mar 2024
0.478
Maximum
Sep 2023
0.1725
Average
0.1573
Median
Debt to Equity Ratio Benchmarks
| Standard BioTools Inc | 0.1128 |
| Ainos Inc | -- |
| Zomedica Corp | 0.00 |
| LENSAR Inc | 0.00 |
| Adagio Medical Holdings Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.73M |
| Total Liabilities (Quarterly) | 5.777M |
| Shareholders Equity (Quarterly) | 6.105M |
| Current Ratio | 1.141 |
| Net Debt Paydown Yield | 0.68% |